(Press-News.org) Scientists at NYU Langone Medical Center have identified a compound, called 2-PMAP, in animal studies that reduced by more than half levels of amyloid proteins in the brain associated with Alzheimer's disease. The researchers hope that someday a treatment based on the molecule could be used to ward off the neurodegenerative disease since it may be safe enough to be taken daily over many years.
"What we want in an Alzheimer's preventive is a drug that modestly lowers amyloid beta and is also safe for long term use," says Martin J. Sadowski, MD, PhD, associate professor of neurology, psychiatry, and biochemistry and molecular pharmacology, who led the research to be published online June 3 in the journal Annals of Neurology. "Statin drugs that lower cholesterol appear to have those properties and have made a big impact in preventing coronary artery disease. That's essentially what many of us envision for the future of Alzheimer's medicine."
The 2-PMAP molecule that Dr. Sadowski's team identified is non-toxic in mice, gets easily into the brain, and lowers the production of amyloid beta and associated amyloid deposits.
The prime target for Alzheimer's prevention is amyloid beta. Decades before dementia begins, this small protein accumulates in clumps in the brain. Modestly lowering the production of amyloid beta in late middle age, and thus removing some of the burden from the brain's natural clearance mechanisms, is believed to be a good prevention strategy. Researchers two years ago reported that something like this happens naturally in about 0.5 percent of Icelanders, due to a mutation they carry that approximately halves amyloid beta production throughout life. These fortunate people show a slower cognitive decline in old age, live longer, and almost never get Alzheimer's.
Prevention of Alzheimer's dementia is now considered more feasible than stopping it after it has begun, when brain damage is already severe. Every prospective Alzheimer's drug in clinical trials has failed even to slow the disease process at that late stage. "The key is to prevent the disease process from going that far," Dr. Sadowski says.
Dr. Sadowski and colleagues screened a library of compounds and found that 2-PMAP reduced the production of amyloid beta's mother protein, known as amyloid precursor protein (APP). The APP protein normally is cut by enzymes in a way that leaves amyloid beta as one of the fragments. Dr. Sadowski's team found that 2-PMAP, even at low, non-toxic concentrations, significantly reduced APP production in test cells, lowering amyloid beta levels by 50 percent or more.
The scientists subsequently found that 2-PMAP had essentially the same impact on APP and amyloid beta in the brains of living mice. The mice were engineered to have the same genetic mutations found in Alzheimer's patients with a hereditary form of the disease, causing overproduction of APP and Alzheimer's-like amyloid deposits. A five-day treatment with 2-PMAP lowered brain levels of APP and, even more so, levels of amyloid beta. Four months of treatment sharply reduced the amyloid deposits and prevented the cognitive deficits that are normally seen in these transgenic mice as they get older.
Dr. Sadowski and his laboratory are now working to make chemical modifications to the compound to improve its effectiveness. But 2-PMAP already seems to have advantages over other amyloid-lowering compounds, he says. One is that it can cross efficiently from the bloodstream to the brain, and thus doesn't require complex modifications that might compromise its effects on APP.
The compound also appears to have a highly selective effect on APP production, by interfering with the translation of APP's gene transcript into the APP protein itself. The best known candidates for Alzheimer's preventives lower amyloid by inhibiting the secretase enzymes that cleave amyloid beta from APP, tending to cause unwanted side-effects via their off target interference with the processing of other client proteins cleaved by these enzymes. A clinical trial of one secretase inhibitor was halted in 2010 after it was found to worsen dementia and cause a higher incidence of skin cancer.
Alzheimer's disease, the most common form of dementia, currently afflicts more than five million Americans, according to the Alzheimer's Association. Unless preventive drugs or treatments are developed, the prevalence of Alzheimer's is expected to triple by 2050.
INFORMATION:
Other NYU Langone researchers contributing to the study were lead author Ayodeji A. Asuni, PhD; Maitea Guridi, MS; Joanna E. Pankiewicz, MD, PhD; and Sandrine Sanchez, PhD.
U.S. Patent No. 8,658,677 was recently issued for the compound discussed in this release. Funding for the research was provided in part by the National Institutes of Health (grants R01 AG31221 and K02 AG34176).
NYULMC
About NYU Langone Medical Center:
NYU Langone Medical Center, a world-class, patient-centered, integrated academic medical center, is one of the nation's premier centers for excellence in clinical care, biomedical research, and medical education. Located in the heart of Manhattan, NYU Langone is composed of four hospitals—Tisch Hospital, its flagship acute care facility; Rusk Rehabilitation; the Hospital for Joint Diseases, the Medical Center's dedicated inpatient orthopaedic hospital; and Hassenfeld Children's Hospital, a comprehensive pediatric hospital supporting a full array of children's health services across the Medical Center—plus the NYU School of Medicine, which since 1841 has trained thousands of physicians and scientists who have helped to shape the course of medical history. The Medical Center's tri-fold mission to serve, teach, and discover is achieved 365 days a year through the seamless integration of a culture devoted to excellence in patient care, education, and research. For more information, go to http://www.NYULMC.org, and interact with us on Facebook, Twitter, and YouTube.
Media Inquiries:
David March
212.404.3528│david.march@nyumc.org
New amyloid-reducing compound could be a preventive measure against Alzheimer's
NYU Langone researchers identify promising treatment target molecule in mice studies
2014-06-03
ELSE PRESS RELEASES FROM THIS DATE:
Screening has prevented half a million colorectal cancers
2014-06-03
New Haven, Conn. – An estimated half a million cancers were prevented by colorectal cancer screening in the United States from 1976 to 2009, report researchers from the Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center at Yale Cancer Center. Their study appears in the journal Cancer.
During this more than 30-year time span, as increasing numbers of men and women underwent cancer screening tests — including fecal occult blood testing, sigmoidoscopies, and colonoscopies — colorectal cancer rates declined significantly, the researchers found.
The ...
Insect repellents more important than ever as tropical tourism increases
2014-06-03
Holidaymakers are being urged to use insect repellent to protect themselves against bites and the diseases they can spread, as trends show travel to tropical countries is rising among Britons.
With the World Cup starting in Brazil next week and holiday season about to get under way, scientists from repellent testing facility arctec at the London School of Hygiene & Tropical Medicine today launch Bug Off - the first ever Insect Repellent Awareness Day to highlight the issue.
They recommend applying repellents containing 20-50% DEET to the skin when in countries with ...
Left-handed fetuses could show effects of maternal stress on unborn babies
2014-06-03
Fetuses are more likely to show left-handed movements in the womb when their mothers are stressed, according to new research.
Researchers at Durham and Lancaster universities say their findings are an indicator that maternal stress could have a temporary effect on unborn babies, adding that their research highlights the importance of reducing stress during pregnancy.
However, the researchers emphasised that their study was not evidence that maternal stress led to fixed left-handedness in infants after birth. They said that some people might be genetically predisposed ...
Study of over 10,000 patients suggests men experience more pain after major surgery
2014-06-03
New research presented at this year's Euroanaesthesia meeting in Stockholm suggests that gender plays a part in pain experienced after surgery, with men feeling more pain following major surgery while women feel more pain after minor procedures. The study is by Dr Andreas Sandner-Kiesling, Dept of Anaesthesiology & Intensive Care, Medical University of Graz, Austria, and colleagues.
"The influence of gender and sexes is a key issue of today's research in medicine. However, current literature in the field of perioperative medicine rarely focuses on this question," says ...
Increased mucins pinned to worsening cystic fibrosis symptoms
2014-06-03
CHAPEL HILL, N.C. – UNC School of Medicine researchers have provided the first quantitative evidence that mucins – the protein framework of mucus – are significantly increased in cystic fibrosis patients and play a major role in failing lung function.
The research, published today in the Journal of Clinical Investigation, shows that a three-fold increase of mucins dramatically increases the water-draining power of the mucus layer. This hinders mucus clearance in the CF lung, resulting in infection, inflammation, and ultimately lung failure.
"Our finding suggests that ...
Nutrition experts: Debate over value of vitamin, mineral supplements is far from over
2014-06-03
CORVALLIS, Ore. – Researchers from the Linus Pauling Institute at Oregon State University and three other institutions have taken issue with recent claims that "the case is closed" on whether or not a multivitamin/mineral supplement should be taken by most people to help obtain needed micronutrients.
In a correspondence to be published Tuesday in the Annals of Internal Medicine, the researchers reasoned that this type of dietary supplement helps fill nutritional gaps, improves general health, might help prevent chronic disease, will cause no harm and is easily worth the ...
Young women fare worse than young men after heart attack
2014-06-02
Women age 55 or younger may fare worse than their male counterparts after having a heart attack, according to new research presented at the American Heart Association's Quality of Care and Outcomes Research Scientific Sessions 2014.
Researchers studied records and interviews of 3,501 people (67 percent women) who had heart attacks in the United States and Spain in 2008-12. One year after their heart attack, women were more likely than men to have:
Poorer physical functioning
Poorer mental functioning
Lower quality of life
More chest pain
Worse physical limitations
"Previous ...
Hispanics cut medication adherence gap after Medicare Part D launch
2014-06-02
Hispanics have reduced the gap with whites in taking prescribed heart medicines since the 2006 launch of Medicare's prescription drug benefit called Medicare Part D, according to a study presented at the American Heart Association's Quality of Care and Outcomes Research 2014 Scientific Sessions.
Researchers reviewed prescription drug data from the national Medical Expenditure Panel for African-American and Hispanic Medicare recipients to find trends in medication adherence in the four years after the launch of Medicare Part D (2001-10).
After Part D, adherence rates ...
Simple change to Medicare Part D would yield $5 billion in savings
2014-06-02
PITTSBURGH, June 2, 2014 – The federal government could save over $5 billion in the first year by changing the way the government assigns Part D plans for Medicare beneficiaries eligible for low-income subsidies, according to new research from the University of Pittsburgh Graduate School of Public Health.
The results of the study, funded by the National Institutes of Health (NIH) and the U.S. Department of Health and Human Services (HHS), will be published in the June issue of the journal Health Affairs.
Medicare Part D provides assistance to beneficiaries below 150 ...
Choosing one drug over another to treat blindness could save Medicare billions
2014-06-02
ANN ARBOR—If all eye doctors prescribed the less expensive of two drugs to treat two common eye diseases of older adults, taxpayer-funded Medicare plans could save $18 billion over a 10-year period, say researchers at the University of Michigan.
Further, patients with the wet form of macular degeneration or who have diabetic macular edema could keep $4.6 billion in co-pays in their wallets, and the rest of the U.S. health care system could save $29 billion in private insurance payments and other costs, according to the team led by David Hutton, assistant professor of ...
LAST 30 PRESS RELEASES:
A map for single-atom catalysts
What about tritiated water release from Fukushima? Ocean model simulations provide an objective scientific knowledge on the long-term tritium distribution
Growing crisis of communicable disease in Canada in tandem with US cuts
Women get better at managing their anger as they age
Illegal shark product trade evident in Australia and New Zealand
New search tool brings 21% better accuracy for robotics developers
New model extracts sentence-level proof to verify events, boosting fact-checking accuracy for journalists, legal teams, and policymakers
Efficient carbon integration of CO₂ in propane aromatization over acidic zeolites
FPGA-accelerated AI for demultiplexing multimode fiber towards next-generation communications
Vitamin D3 nanoemulsion significantly improves core symptoms in children with autism: A clinical trial
Microfluidic point-of-care device accurately measures bilirubin in blood serum: A pilot study
Amygdalin shows strong binding and stabilizing effects on HER2 receptor: A computational study for breast cancer therapy
Bond behavior of FRP bars in concrete under reversed cyclic loading: an experimental study
Milky Way-like galaxy M83 consumes high-speed clouds
Study: What we learned from record-breaking 2021 heat wave and what we can expect in the future
Transforming treatment outcomes for people with OCD
Damage from smoke and respiratory viruses mitigated in mice via a common signaling pathway
New software tool could help better understand childhood cancer
Healthy lifestyle linked to lower diverticulitis risk, irrespective of genetic susceptibility
Women 65+ still at heightened risk of cervical cancer caused by HPV
‘Inflammatory’ diet during pregnancy may raise child’s diabetes type 1 risk
Effective therapies needed to halt rise in eco-anxiety, says psychology professor
Nature-friendly farming boosts biodiversity and yields but may require new subsidies
Against the odds: Endometriosis linked to four times higher pregnancy rates than other causes of infertility, new study reveals
Microplastics discovered in human reproductive fluids, new study reveals
Family ties and firm performance: How cousin marriage traditions shape informal businesses in Africa
Novel flu vaccine adjuvant improves protection against influenza viruses, study finds
Manipulation of light at the nanoscale helps advance biosensing
New mechanism discovered in ovarian cancer peritoneal metastasis: YWHAB restriction drives stemness and chemoresistance
New study links blood metabolites and immune cells to increased risk of urolithiasis
[Press-News.org] New amyloid-reducing compound could be a preventive measure against Alzheimer'sNYU Langone researchers identify promising treatment target molecule in mice studies